Gene Editing Has Arrived
A new gene therapy has just been approved as a treatment for the inherited blood disease, sickle cell disease, in the UK and...
Read moreDetailsA new gene therapy has just been approved as a treatment for the inherited blood disease, sickle cell disease, in the UK and...
Read moreDetailsIn the latest edition of its annual coal market report, the International Energy Agency (IEA) projects that global coal demand,...
Read moreDetailsUp to $890 million in funding has been made available for three projects — by the U.S. Department of Energy's...
Read moreDetailsCircular Economy (CE) is widely recognized as the new economic model aiming to maintain the value of materials, parts, and...
Read moreDetailsThis month, the approval of an RNA-based vaccine for COVID-19 took another step forward with the endorsement last week by Japanese...
Read moreDetails
Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.